Restaurants in every major city now offer not just delivery and takeout — minor lifelines for the industry — but also boxes of the ingredients used in their kitchens, sometimes with recipes or assembly instructions included. Chefs are boxing up their hummus and selling partly assembled meals to be finished at home — all the supplies for beef barbacoa tacos; a clay pot of biryani sealed under a lid of dough that needs half an hour in the oven; cookies with decorating kits; meats that had been aged for expense account spenders, now for you. … [Read more...] about Coronavirus impact | Your kitchen can be as well stocked as restaurants now
Between Rossari Biotech, Yes Bank FPO, and Bharat Bond ETF, if we take a long-term view and moderate to high-risk profile, we like Rossari the most, given that it ticks the right boxes when it comes to sector and growth profile. At the offer price, Rossari would be valued at a premium relative to some of its larger peers (P/E of around 36) like Vinati, Atul, and Fine Organics. This valuation could be justified given its higher revenue and net income CAGR numbers. … [Read more...] about Rossari Biotech IPO, Bharat Bond ETF & Yes Bank FPO: Where should investors put their money?
In its latest update on the drug, Gilead said on July 10 that an analysis showed remdesivir helped reduce the risk of death in severely ill COVID-19 patients but cautioned that rigorous clinical trials were needed to confirm the benefit. … [Read more...] about One in three South Korean COVID-19 patients improved with remdesivir
By no chance is this list of anti-COVID gear a final one either. According to Rajiv Nath, Coordinator of the COVID PPE Support Group, which is working with the Department of Pharmaceuticals, “this list is a dynamic one, which changes every two weeks.” One thing is for certain. Most of these goods were imported not too long ago. Now they are wholly indigenous. … [Read more...] about From PPE kits to sanitisers to ventilators, COVID-19 has sparked off an indigenous cottage industry boom
>> Dr Reddy's Laboratories Ltd on Saturday announced it has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. that will grant the city-based drug maker right to register, manufacture and sell Gilead's investigational drug, Remdesivir, a potential treatment for COVID-19, in 127 countries including India. … [Read more...] about Coronavirus wrap June 13: Loss of smell, taste added to list of COVID-19 symptoms